Author

A. J. Korman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:chicken / avian· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Chiechi· 1 shared A. Galstyan· 1 shared A. M. Christiano· 1 shared A. M. De Marzo· 1 shared A. Obradovic· 1 shared A. V. Ljubimov· 1 shared C. G. Drake· 1 shared C. J. Bieberich· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chiechi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination With Nivolumab

K. Thudium, M. Selby, J. A. Zorn, G. Rak, X.-T. Wang, R. T. Bunch, J. M. Hogan, P. Strop, A. J. Korman

This paper characterizes relatlimab, a LAG-3-blocking antibody, showing it enhances anti-tumor activity when combined with nivolumab in preclinical models and is well-tolerated in monkeys.

bioRxiv · Jan 24, 2022Cancer Biology

Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression

Z. A. Lopez-Bujanda, M. C. Haffner, M. G. Chaimowitz, N. Chowdhury, N. J. Venturini, A. Obradovic, C. S. Hansen, J. Jackow, K. S. Sfanos, C. J. Bieberich, P. J. Hurley, M. J. Selby, A. J. Korman, A. M. Christiano, A. M. De Marzo, C. G. Drake

This study identifies IL-8 secretion from prostate cancer cells during castration as a driver of myeloid infiltration and cancer progression, suggesting targeting IL-8/CXCR2 with immunotherapy could delay castration resistance.

bioRxiv · May 27, 2019Immunology

Nano immunoconjugates crossing blood-brain barrier activate local brain tumor immune system for glioma treatment

A. Galstyan, A. Chiechi, A. J. Korman, T. Sun, L. L. Isreal, O. Braubach, R. Patil, E. Shatalova, V. A. Ljubimov, J. Markman, Z. Grodzinski, K. L. Black, M. L. Penichet, E. Holler, A. V. Ljubimov, , J. Y. Ljubimova

This study develops nano immunoconjugates that cross the blood-brain barrier to activate local immune responses against gliomas, improving survival in treated mice.

bioRxiv · Nov 9, 2018 · PreprintImmunology